Siemens AG could cut as many as 1,600 jobs from its health care business, including up to 8 percent of its diagnostics group, according to reports Wednesday.
In an interview with Swiss newspaper Finanz & Wirtschaft, CFO Michael Sen said the diagnostics group, which makes blood and urine testing systems, had underperformed. He said they would likely cut between 6 and 8 percent of its 15,000 global workforce, according to accounts of the interview given by MarketWatch and Bloomberg.
Overall, in the last quarter, growth of new orders and sales in health care was sluggish, and profitability was down, according to the reports.
